Falklands Tribune
SEE OTHER BRANDS

The latest news from the Falkland Islands

Veterinary CRO and CDMO Market Size Worth USD 13.65 Bn by 2032 | Global Growth at 9.2% CAGR (2024–2032)

Veterinary CRO and CDMO Market

Veterinary CRO and CDMO Market

Veterinary CRO and CDMO Market Segment

Veterinary CRO and CDMO Market Segment

The Veterinary CRO and CDMO Market was valued at USD 6.75 Bn in 2024 and is expected to reach USD 13.65 Bn by 2032, at a CAGR of 9.2% during the forecast period

Surging pet populations, intensified livestock production, and AI-driven R&D are transforming the Veterinary CRO and CDMO Market”
— Navneet Kaur
WILMINGTON, DE, UNITED STATES, September 18, 2025 /EINPresswire.com/ -- The Veterinary CRO and CDMO Market, valued at USD 6.75 Bn in 2024, is projected to reach USD 13.65 Bn by 2032, growing at 9.2% CAGR. Rising pet ownership, livestock demand, and animal healthcare outsourcing are driving growth in veterinary contract research and manufacturing services.

Veterinary CRO and CDMO Market Overview

Stellar reports reveal the Veterinary CRO and CDMO Market, valued at USD 6.75 Bn in 2024 and set to reach USD 13.65 Bn by 2032 at 9.2% CAGR, is being revolutionized by AI, data analytics, and digital platforms. Rising pet ownership, livestock demand, and innovative animal healthcare solutions are fueling rapid growth. North America leads, Asia-Pacific surges fastest, and industry giants like Charles River, Labcorp, Zoetis, and WuXi AppTec are racing through strategic M&A and tech innovation, who will dominate the next frontier of veterinary pharmaceuticals?

To know the most attractive segments, click here for a free sample of the report: https://www.stellarmr.com/report/req_sample/veterinary-cro-and-cdmo-market/2811

“Rising Pet Population and Livestock Demand Propel Veterinary CRO and CDMO Market, Who Will Dominate Innovation?”

Key Growth Drivers: Pet Ownership & Livestock Expansion

The rising global pet population and intensified livestock production are fueling the Veterinary CRO and CDMO Market, driving demand for specialized drugs, vaccines, and innovative animal healthcare solutions. As veterinary companies increasingly turn to CROs and CDMOs for advanced R&D, testing, and product development, the market is poised for dynamic growth, raising the question: which service providers will lead the next wave of innovation in animal health?

“AI, Data Analytics, and Digital Platforms Set to Redefine the Veterinary CRO and CDMO Market, Who Will Dominate Innovation?”

Next-generation technologies are revolutionizing the Veterinary CRO and CDMO Market, as AI, data analytics, and digital platforms accelerate drug development and enhance R&D precision. Rising demand for pharmacovigilance and regulatory-compliant solutions positions specialized CROs/CDMOs to capitalize on integrated, technology-driven animal healthcare opportunities. Which innovators will define the future of veterinary pharmaceuticals?

“High Development Costs and Compliance Challenges Shape the Veterinary CRO and CDMO Market, Which Leaders Will Thrive?”

Market Challenges: Compliance, Costs, and Regulation

Rising development costs and a complex, evolving regulatory landscape are shaping the growth trajectory of the Veterinary CRO and CDMO Market, challenging providers to optimize efficiency while ensuring compliance. Which service providers will leverage regulatory expertise and strategic innovation to turn these hurdles into competitive advantage and capture the next wave of market opportunity?

“Navigating Complexity: Which Leaders Will Transform Challenges into Growth in the Veterinary CRO and CDMO Market?”

Veterinary CRO and CDMO Market Segmentation

The Veterinary CRO and CDMO Market is witnessing rapid evolution, driven by surging demand for livestock and companion animal vaccines, drugs, and diagnostics. While the development segment dominates due to specialized expertise in late-phase testing and regulatory compliance, high costs and complex regulations challenge growth and project scope. Which service providers will leverage technical prowess and regulatory mastery to turn these hurdles into competitive advantage and capture the next wave of animal health innovation?

Veterinary CRO and CDMO Market Key Trends:

“Rising Pet Ownership and Companion Animal Healthcare: The growing adoption of pets and escalating expenditure on their health is driving demand for specialized veterinary medications, biologics, and medical devices, creating significant growth opportunities in the Veterinary CRO and CDMO Market.”

“Technical Excellence of CROs and CDMOs: Advanced technological capabilities, state-of-the-art equipment, and specialized expertise of contract research and development organizations are pivotal drivers fueling growth in the Veterinary CRO and CDMO Market.”

Over 1 billion pets worldwide and 14% livestock growth by 2030 are fueling veterinary CRO and CDMO demand.

“Veterinary CRO and CDMO Market 2024: Which Regions and Innovators Will Lead the Next Global Growth Surge?”

Regional Outlook: North America Leads, APAC Surges Fastest

The Veterinary CRO and CDMO Market sees North America leading in 2024, powered by cutting-edge animal health infrastructure, high R&D investment, and stringent regulatory standards driving specialized outsourcing. Europe trails closely, but Asia-Pacific is emerging as the fastest-growing frontier, fueled by booming animal health industries and cost efficiencies. With global demand surging, the question remains: which regions and innovators will dominate the next transformative wave of the Veterinary CRO and CDMO Market?

“Veterinary CRO and CDMO Market: Who Will Lead the Next Wave of Innovation Amid Fierce Competition and Strategic M&A?”

To know the most attractive segments, click here for a free sample of the report: https://www.stellarmr.com/report/req_sample/veterinary-cro-and-cdmo-market/2811

Competitive Landscape: Key Players & Innovation

Top veterinary CRO and CDMO companies shaping this USD 13.65 Bn market include Charles River, Labcorp, Zoetis, WuXi AppTec, and ICON. The Veterinary CRO and CDMO Market is fiercely competitive, led by giants like Charles River, Labcorp, and Zoetis with end-to-end solutions, global reach, and strong R&D. Niche players excel in precision medicine and diagnostics, while M&A, AI, and advanced analytics accelerate innovation. With moves like Charles River’s expanded biosafety testing and Zoetis’ gene therapy acquisition, who will shape the next era of veterinary pharmaceutical leadership?

Veterinary CRO and CDMO Market Key Players

North America

Labcorp Drug Development (USA)
Charles River Laboratories (USA)
IDEXX Laboratories Inc. (USA)
Inotiv Inc. (USA)
Vetio Animal Health (USA)
Zoetis Inc. / Nexvet (USA)
Pharmaceutical Product Development, LLC - PPD (USA)
Syneos Health Inc. (USA)
ICON plc (Ireland / USA operations)
Medpace (USA)
Envigo (USA)
VetPharm, Inc. (USA)
MPI Research (USA)

Europe

KLIFOVET GmbH (Germany)
Knoell – Triveritas (Germany)
VETSPIN Srl (Italy)
Veterinary Research Management – VRM Ltd. (United Kingdom)
Cebiphar (France)
Ondax Scientific UK Ltd. (United Kingdom)
Ridgeway Research Ltd. (United Kingdom)
Drayton Animal Health Ltd. (United Kingdom)
Arcoblu S.r.l. (Italy)

Asia Pacific

WuXi AppTec (China)
Sai Life Sciences Ltd. (India)
Elanco India Private Limited (India)

Middle East and Africa

Dawa Life Sciences (Kenya)
Botswana Vaccine Institute – BVI (Botswana)
Julphar – Gulf Pharmaceutical Industries (United Arab Emirates)

South America

Eurofarma Laboratórios S.A. (Brazil)
Ourofino Saúde Animal (Brazil)

Related Reports:

Vulvar Cancer Market: https://www.stellarmr.com/report/vulvar-cancer-market/2812

Burial Insurance Market: https://www.stellarmr.com/report/burial-insurance-market/2804

Neurofibrosarcoma Treatment Market: https://www.stellarmr.com/report/Neurofibrosarcoma-Treatment-Market/2800

Pseudotumor Cerebri Market: https://www.stellarmr.com/report/Pseudotumor-Cerebri-Market/2799

Resuscitation Devices Market: https://www.stellarmr.com/report/Resuscitation-Devices-Market/2798

About Stellar Market Research:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Lumawant Godage
Stellar Market Research
+91 96073 65656
email us here
Visit us on social media:
LinkedIn
Instagram
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions